Terms: = Lymphoma AND TG, Thyroglobulin AND Prognosis
24 results:
1.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract] [Full Text] [Related]
2. Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab.
Wang F; Lu L; Chen H; Yue Y; Sun Y; Yan F; He B; Lin R; Gu W
Ann Hematol; 2023 Feb; 102(2):393-402. PubMed ID: 36670246
[TBL] [Abstract] [Full Text] [Related]
3. The Relationship Between Primary Thyroid lymphoma and Various Types of Thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease.
Suzuki N; Watanabe N; Noh JY; Yoshimura R; Mikura K; Kinoshita A; Suzuki A; Mitsumatsu T; Fukushita M; Matsumoto M; Yoshihara A; Katoh R; Sugino K; Ito K
Thyroid; 2022 May; 32(5):552-559. PubMed ID: 35229626
[No Abstract] [Full Text] [Related]
4. [Comparisons of clinical characteristics and prognosis between patients with primary and secondary thyroid lymphoma].
Sun R; Shi Q; Shen R; Qian Y; Xu PP; Chen S; Wang L; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):568-572. PubMed ID: 32397019
[No Abstract] [Full Text] [Related]
5. Genetic heterogeneity and mutational signature in Chinese Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Liu F; Wang Z; Zhou X; Liu Q; Chen G; Xiao H; Yin W; Nakamura S; Rao H
PLoS One; 2018; 13(8):e0201546. PubMed ID: 30106962
[TBL] [Abstract] [Full Text] [Related]
6. Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.
Tuzlak S; Haschka MD; Mokina AM; Rülicke T; Cory S; Labi V; Villunger A
FEBS J; 2018 Apr; 285(8):1403-1418. PubMed ID: 29498802
[TBL] [Abstract] [Full Text] [Related]
7. Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic Leukemia.
Ghavami A; Fathpour G; Amirghofran Z
Pathol Oncol Res; 2018 Jul; 24(3):653-662. PubMed ID: 28828696
[TBL] [Abstract] [Full Text] [Related]
8. Amlexanox Downregulates S100A6 to Sensitize
Tamai H; Yamaguchi H; Miyake K; Takatori M; Kitano T; Yamanaka S; Yui S; Fukunaga K; Nakayama K; Inokuchi K
Cancer Res; 2017 Aug; 77(16):4426-4433. PubMed ID: 28646023
[TBL] [Abstract] [Full Text] [Related]
9. Interleukin-23 Receptor Gene Variants in Acute Lymphoblastic Leukemia and Their Relation to Prognostic Factors.
Zareinejad M; Samiei A; Valibeigi B; Gholami T; Zareifar S; Amirghofran Z
Iran J Immunol; 2017 Mar; 14(1):59-72. PubMed ID: 28341819
[TBL] [Abstract] [Full Text] [Related]
10. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value.
Uskudar Teke H; Gulbas Z; Bal C
J BUON; 2014; 19(1):191-7. PubMed ID: 24659663
[TBL] [Abstract] [Full Text] [Related]
11. T-cell receptor diversity prevents T-cell lymphoma development.
Newrzela S; Al-Ghaili N; Heinrich T; Petkova M; Hartmann S; Rengstl B; Kumar A; Jäck HM; Gerdes S; Roeder I; Hansmann ML; von Laer D
Leukemia; 2012 Dec; 26(12):2499-507. PubMed ID: 22643706
[TBL] [Abstract] [Full Text] [Related]
12. Medullary thyroid carcinoma, small cell variant, as a diagnostic challenge on fine needle aspiration: a case report.
Yerly S; Triponez F; Meyer P; Kumar N; Bongiovanni M
Acta Cytol; 2010; 54(5 Suppl):911-7. PubMed ID: 21053568
[TBL] [Abstract] [Full Text] [Related]
13. Concomitant thyroid Malt lymphoma and papillary thyroid carcinoma.
Melo GM; Sguilar DA; Petiti CM; Eichstaedt AG; Caiado RR; Souza RA
Arq Bras Endocrinol Metabol; 2010 Jun; 54(4):425-8. PubMed ID: 20625656
[TBL] [Abstract] [Full Text] [Related]
14. Immunohistochemical profile and treatment of uncommon types of thyroid carcinomas.
Shvero J; Koren R; Shpitzer T; Feinmesser R; Segal K
Oncol Rep; 2003; 10(6):2075-8. PubMed ID: 14534746
[TBL] [Abstract] [Full Text] [Related]
15. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.
Rassidakis GZ; Claret FX; Lai R; Zhang Q; Sarris AH; McDonnell TJ; Medeiros LJ
Clin Cancer Res; 2003 Mar; 9(3):1121-8. PubMed ID: 12631617
[TBL] [Abstract] [Full Text] [Related]
16. [Recent progress in radionuclide therapy].
Kasagi K; Iwata M; Misaki T; Konishi J; Sakahara H
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Nov; 60(13):729-37. PubMed ID: 11140321
[TBL] [Abstract] [Full Text] [Related]
17. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
Pieters R; den Boer ML; Durian M; Janka G; Schmiegelow K; Kaspers GJ; van Wering ER; Veerman AJ
Leukemia; 1998 Sep; 12(9):1344-8. PubMed ID: 9737681
[TBL] [Abstract] [Full Text] [Related]
18. [Colon cancer in the experience of Surgical Clinic No. 1, Tîrgu-Mureş. Late postoperative results].
Coroş MF; Copotoiu C; Baghiu M; Bud V
Chirurgia (Bucur); 1997; 92(4):227-35. PubMed ID: 9445636
[TBL] [Abstract] [Full Text] [Related]
19. Radiotherapy in the management of thyroid cancer.
Harmer CL
Ann Acad Med Singap; 1996 May; 25(3):413-9. PubMed ID: 8876909
[TBL] [Abstract] [Full Text] [Related]
20. Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
Leuk Res; 1992 Sep; 16(9):873-80. PubMed ID: 1405718
[TBL] [Abstract] [Full Text] [Related]
[Next]
